Reports

Ideas That Generate Results

Global Antibody Drug Conjugate Drug Sales, Pipeline Analysis (By Phase, Linker, Technology, and Indication) & Market Forecast to 2023

Global Antibody Drug Conjugate Drug Sales, Pipeline Analysis (By Phase, Linker, Technology, and Indication) & Market Forecast to 2023

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Aug, 2018| No. of Pages : 110

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 2000.00
CD-ROM Mail Delivery
US$ 2400.00
Hard Copy Mail Delivery
US$ 2400.00
Electronic Access - Multi-User License
US$ 3000.00
List of Figures:
 
Figure 3-1: ADC - Mechanism of Action
Figure 4-1: Global - ADC Market (Billion US$), 2016, 2017 & 2023
Figure 5-1: Global - ADCETRIS Sales (Million US$), 2016 & 2017
Figure 5-2: Global - Kadcyla Sales (Million US$), 2016 & 2017
Figure 6-1: Global - ADCs Pipeline by Developing Organizations (%), 2017
Figure 6-2: Global - ADC Pipeline of Companies by Clinical Phase (%), 2017
Figure 6-3: Global - ADC Pipeline of Companies by Indication (%), 2017
Figure 6-4: Global - ADC Pipeline of Companies by Drug (%), 2017
Figure 6-5: Global - ADC Pipeline of Companies by Type of Linker (%), 2017
Figure 6-6: Global - ADC Pipeline of Companies by Technology (%), 2017
Figure 6-7: Global - ADC Pipeline of Research Organization by Clinical Phase (%), 2017
Figure 6-8: Global - ADC Pipeline of Research Organization by Indication (%), 2017
Figure 6-9: Global - ADC Pipeline of Research Organization by Drug (%), 2017
Figure 6-10: Global - ADC Pipeline of Research Organization by Type of Linker (%), 2017
Figure 6-11: Global - ADC Pipeline of Research Organization by Technology (%), 2017
Figure 11-1: F. Hoffman-La Roche Ltd. - Group Sales Breakup by Business Segments (%), 2016
Figure 11-2: Pfizer Inc. - Revenue Breakup by Business Segments (%), 2016
Figure 11-3: Pfizer Inc. - Revenue Breakup by Geography (%), 2016
Figure 11-4: Bayer AG - Sales Breakup by Business Segments (%), 2016
Figure 11-5: Bayer AG - Net Sales Breakup by Geography (%), 2016
Figure 11-6: Takeda Pharmaceutical Company Limited - Ethical Drugs Revenue Breakup by Geography (%), 2016
Figure 11-7: Immunomedics, Inc. - Revenue Breakup by Geography (%), 2017
 
List of Tables:
 
Table 5-1: Global - Incidence of Hodgkin Lymphoma, 2012, 2015, 2020, & 2025
Table 5-2: Global - Incidence of Non-Hodgkin Lymphoma, 2012, 2015, 2020, & 2025
Table 5-3: Major Ongoing Trials for ADCETRIS
Table 5-4: Global - Incidence of Breast Cancer, 2012, 2015, 2020, & 2025
Table 5-5: Major Ongoing Trials for Kadcyla 
Table 5-6: Major Ongoing Trials for Mylotarg
Table 5-7: Major Ongoing Trials for Besponsa
Table 6-1: Global - ADC Pipeline of Companies
Table 6-2: Global - ADC Pipeline of Research Organization
Table 10-1: Major Strategic Alliances in the Global Antibody Drug Conjugates Industry (2014-2017)
Table 11-1: Seattle Genetics, Inc. - Key Financials (Million US$), 2014-2016
Table 11-2: Seattle Genetics, Inc. - ADC Product Portfolio
Table 11-3: Seattle Genetics, Inc. - ADCs in Pipeline
Table 11-4: F. Hoffman-La Roche Ltd. - Key Financials (Million US$), 2014-2016
Table 11-5: F. Hoffman-La Roche Ltd. - ADC Product Portfolio
Table 11-6: F. Hoffman-La Roche Ltd. - ADCs in Pipeline
Table 11-7: Pfizer Inc. - Key Financials (Million US$), 2014-2016
Table 11-8: Pfizer Inc. - ADC Product Portfolio
Table 11-9: Pfizer Inc. - ADCs in Pipeline
Table 11-10: ImmunoGen, Inc. - Key Financials (Million US$), 2014-2016
Table 11-11: ImmunoGen, Inc. - ADCs in Pipeline
Table 11-12: Bayer AG - Key Financials (Million US$), 2014-2016
Table 11-13: Bayer AG - ADCs in Pipeline 
Table 11-14: Takeda Pharmaceutical Company Limited - Key Financials (Million US$), 2014-2016 
Table 11-15: Takeda Pharmaceutical Company Limited - ADCs in Pipeline 
Table 11-16: Immunomedics, Inc. - Key Financials (Million US$), 2015-2017
Table 11-17: Immunomedics, Inc. - ADCs in Pipeline
Table 11-18: Oxford BioTherapeutics - ADCs in Pipeline
Table 11-19: Concortis Biotherapeutics - ADCs in Pipeline
Table 11-20: NBE-Therapeutics - ADCs in Pipeline
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.